A medication known as spironolactone may aid the treatment of alcohol use disorder, according to a new study published in Molecular Psychiatry. The research was led by scientists at the U.S. National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA). “Alcohol use disorder (AUD) affects 14.5 million people in the United States alone, yet less than 10% of people with AUD receive any treatment, despite the availability of behavioral treatments and three medications approved for AUD,” explained study author Lorenzo Leggio, a physician-scientist and s…